Expertise in
4
conditions

Katja Werlenius

Goeteborg, O, SE 
Expertise in
4
conditions
Goeteborg, O, SE 

Overview

Katja Werlenius practices practicing medicine in Goeteborg, Sweden.

Ms. Werlenius is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Astrocytoma, Glioblastoma, Glioma, and Gliomatosis Cerebri.

She is actively involved in clinical research, co-authoring 17 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Goeteborg, O, Sweden

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

DIRECT (DIsulfiram REsponse as add-on to ChemoTherapy in Recurrent) Glioblastoma: A Randomized Controlled Trial
DIRECT (DIsulfiram REsponse as add-on to ChemoTherapy in Recurrent) Glioblastoma: A Randomized Controlled Trial
Enrollment Status: Completed
Publish Date: March 18, 2021
Intervention Type: Drug, Dietary supplement
Study Phase: Phase 2/Phase 3
An Open Label, Randomised, Phase II Study to Investigate the Efficacy and Safety of ALECSAT Treatment as an add-on Therapy to Radiotherapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma
An Open Label, Randomised, Phase II Study to Investigate the Efficacy and Safety of ALECSAT Treatment as an add-on Therapy to Radiotherapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma
Enrollment Status: Completed
Publish Date: April 30, 2020
Intervention Type: Radiation, Biological, Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

17 Total Publications

Radiotherapy quality assurance in the PRO-GLIO trial: results from a dummy run comparing experts across twelve institutions in two Scandinavian countries.
Radiotherapy quality assurance in the PRO-GLIO trial: results from a dummy run comparing experts across twelve institutions in two Scandinavian countries.
Journal: Clinical and translational radiation oncology
Published: May 03, 2026

Frequently Asked Questions about Katja Werlenius

Is Katja Werlenius a top-rated expert for Astrocytoma?

MediFind is an objective health platform that identifies experts based on real-world data. Katja Werlenius is classified as an Advanced expert for Astrocytoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Katja Werlenius participate in research or clinical trials?

Yes. Katja Werlenius has published 17 articles and abstracts on conditions like Astrocytoma. You can view a list of Katja Werlenius's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Werlenius's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile